Skip to main content
Neuronetics, Inc. (STIM)
NASDAQ: STIM · Real-Time Price · USD
1.340
-0.080 (-5.63%)
At close: Feb 27, 2026, 4:00 PM EST
1.360
+0.020 (1.49%)
After-hours: Feb 27, 2026, 7:50 PM EST

Neuronetics Revenue

Neuronetics had revenue of $37.30M in the quarter ending September 30, 2025, with 101.28% growth. This brings the company's revenue in the last twelve months to $129.87M, up 78.62% year-over-year. In the year 2024, Neuronetics had annual revenue of $74.89M with 4.96% growth.

Revenue (ttm)
$129.87M
Revenue Growth
+78.62%
P/S Ratio
0.71
Revenue / Employee
$181,387
Employees
716
Market Cap
91.77M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202474.89M3.54M4.96%
Dec 31, 202371.35M6.14M9.42%
Dec 31, 202265.21M9.89M17.89%
Dec 31, 202155.31M6.07M12.32%
Dec 31, 202049.24M-13.41M-21.41%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Accuray 436.97M
Xtant Medical Holdings 133.08M
Pulmonx 91.66M
MaxCyte 34.42M
Baird Medical Investment Holdings 31.86M
Sensus Healthcare 27.48M
QT Imaging Holdings 18.93M
Hyperfine 10.59M
Revenue Rankings

STIM News

More News